Enbrel, Dupixent, Rinvoq, Tremfya, Taltz and other biologics for psoriasis, rheumatoid arthritis, Crohn's disease, and inflammatory conditions. Most offer $0 copay for eligible patients.
We'll email you when new manufacturer programs, coupons, or savings cards become available for your medications.
No spam. Unsubscribe anytime.
Most biologic manufacturers offer $0 copay programs for commercially insured patients. For uninsured patients, patient assistance programs can provide medication free of charge.
Biologic medications for autoimmune conditions are among the most expensive drugs on the market — often $20,000–$80,000 per year at retail. But virtually every major biologic has a manufacturer copay card or patient assistance program that can bring costs to $0–$5/month for commercially insured patients.
For commercially insured patients: Copay assistance cards are the most common route. Programs typically cap annual out-of-pocket costs at $0–$5/month for brands like Dupixent, Enbrel, and Rinvoq.
For uninsured or Medicare patients: Patient assistance programs provide free medication based on income. Most manufacturers also have Bridge programs to provide medication while insurance approval is pending.
Sanofi's Dupixent MyWay program can bring costs to $0/month for eligible commercially insured patients. Uninsured patients or those with government insurance may qualify for free medication through the Dupixent patient assistance program. Retail price is approximately $3,700/month.
Yes. Amgen's Enbrel SupportPlus program offers significant savings for commercially insured patients. The Enbrel patient assistance program may provide free medication to uninsured patients who meet income requirements. Some patients pay $5–$20/month with the savings card.
Yes, virtually every major biologic has a manufacturer patient assistance program that can provide medication free of charge to uninsured or underinsured patients who meet income requirements. These programs typically require proof of income and a prescription from your doctor.
A biologic is a complex medication made from living cells (e.g., Humira, Enbrel). A biosimilar is an FDA-approved medicine highly similar to an approved biologic — the generic-equivalent for biologics. Biosimilars for Humira launched in 2023 at significantly lower prices. Ask your prescriber if a biosimilar is appropriate for your condition.